Insider Transactions in Q1 2024 at New Amsterdam Pharma CO N.V. (NAMS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2024
|
James N Topper |
BUY
Open market or private purchase
|
Indirect |
8,429
+0.28%
|
$177,009
$21.5 P/Share
|
|
Mar 26
2024
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
190,476
-100.0%
|
$3,999,996
$21.5 P/Share
|
|
Mar 26
2024
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
11,197
-5.55%
|
$246,334
$22.72 P/Share
|
|
Mar 26
2024
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
201,673
+50.0%
|
-
|
|
Feb 13
2024
|
Louis G Lange |
BUY
Open market or private purchase
|
Indirect |
5,000
+16.73%
|
$95,000
$19.0 P/Share
|